Ask AI
MAXILUS
MAXILUS: Primary Analysis of the Phase III Trial of Luspatercept Initiation at Maximum-Approved Dose in Patients With Lower-Risk MDS Requiring Transfusions

Released: July 08, 2026

Activity

Progress
1
Course Completed
Activity Information

Released: July 08, 2026